BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Kidney
,
Metabolism of nitric oxide
,
Tamoxifen
,
rs2230926
,
MDM2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Pro-epidermal growth factor
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Kidney medulla
Kidney cortex
Kidney
Skeletal muscle
Jejunum
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Hypomagnesemia
Transplanted organ rejection
Kidney finding
Kidney transplant failure and rejection
Renal interstitial fibrosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
eplerenone
Buparlisib
zopiclone
beta-cyclodextrin-benzaldehyde
monorden
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
RAPGEF3
PLN
FH
ETS2
UGDH
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Renal cell carcinomas - Clear cell, papillary, chromophobe, and oncocytoma
Acute cellular injury responses in mouse renal ischemic reperfusion injury
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Pro-epidermal growth factor
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Efficacy of SNX-5422 in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Cancers
Radiotherapy Alternates Human Epidermal Growth Factor 2 (Her2) Expression in Human Breast Cancer
Talazoparib For Neoadjuvant Treatment Of Germline BRCA1/2 Mutation Patients With Early Human Epiderm…
Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell L…
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ